Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Equity Average (2016 - 2025)

Historic Equity Average for Rockwell Medical (RMTI) over the last 15 years, with Q3 2025 value amounting to $33.7 million.

  • Rockwell Medical's Equity Average rose 2811.16% to $33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.7 million, marking a year-over-year increase of 2811.16%. This contributed to the annual value of $26.9 million for FY2024, which is 5220.78% up from last year.
  • Rockwell Medical's Equity Average amounted to $33.7 million in Q3 2025, which was up 2811.16% from $31.0 million recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Equity Average peaked at $33.7 million during Q3 2025, and registered a low of -$1.1 million during Q1 2022.
  • In the last 5 years, Rockwell Medical's Equity Average had a median value of $21.0 million in 2024 and averaged $19.6 million.
  • As far as peak fluctuations go, Rockwell Medical's Equity Average plummeted by 10376.35% in 2022, and later soared by 127288.73% in 2023.
  • Rockwell Medical's Equity Average (Quarter) stood at $6.8 million in 2021, then surged by 121.8% to $15.1 million in 2022, then soared by 41.55% to $21.4 million in 2023, then soared by 44.18% to $30.9 million in 2024, then increased by 9.25% to $33.7 million in 2025.
  • Its last three reported values are $33.7 million in Q3 2025, $31.0 million for Q2 2025, and $32.1 million during Q1 2025.